Daiwa Securities Group Inc. Atreca, Inc. Transaction History

Daiwa Securities Group Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$2.87 - $6.29 $186 - $408	-65 Closed	0 $0
Q4 2020 Feb 04, 2021	SELL	$13.03 - $17.09 $768 - $1,008	-59 Reduced 47.58%	65 $1,000
Q4 2019 Jan 31, 2020	BUY	$9.68 - $18.67 $1,200 - $2,315	124 New	124 $2,000

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.